Your browser doesn't support javascript.
loading
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe.
Feldman, H H; Doody, R S; Kivipelto, M; Sparks, D L; Waters, D D; Jones, R W; Schwam, E; Schindler, R; Hey-Hadavi, J; DeMicco, D A; Breazna, A.
Affiliation
  • Feldman HH; Division of Neurology, University of British Columbia, UBCH Clinic for Alzheimer's Disease and Related Disorders, Vancouver, Canada. hfeldman@interchange.ubc.ca
Neurology ; 74(12): 956-64, 2010 Mar 23.
Article in En | MEDLINE | ID: mdl-20200346
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Alzheimer Disease / Heptanoic Acids Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2010 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Alzheimer Disease / Heptanoic Acids Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 2010 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos